Cargando…
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovere...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000578/ https://www.ncbi.nlm.nih.gov/pubmed/36900258 http://dx.doi.org/10.3390/cancers15051466 |
_version_ | 1784903912762900480 |
---|---|
author | Boyero, Laura Noguera-Uclés, José Francisco Castillo-Peña, Alejandro Salinas, Ana Sánchez-Gastaldo, Amparo Alonso, Miriam Benedetti, Johana Cristina Bernabé-Caro, Reyes Paz-Ares, Luis Molina-Pinelo, Sonia |
author_facet | Boyero, Laura Noguera-Uclés, José Francisco Castillo-Peña, Alejandro Salinas, Ana Sánchez-Gastaldo, Amparo Alonso, Miriam Benedetti, Johana Cristina Bernabé-Caro, Reyes Paz-Ares, Luis Molina-Pinelo, Sonia |
author_sort | Boyero, Laura |
collection | PubMed |
description | SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovered its deregulated target genes in this disease. Additionally, we found five downstream target genes that were correlated with worse overall survival in non-small cell lung cancer. We conclude that C19MC and MIR371-3 are key players in lung cancer because their polycistronic epigenetic regulation leads to differential tumor expression, affecting downstream targets with prognostic value. ABSTRACT: Epigenetic mechanisms have emerged as an important contributor to tumor development through the modulation of gene expression. Our objective was to identify the methylation profile of the imprinted C19MC and MIR371-3 clusters in patients with non-small cell lung cancer (NSCLC) and to find their potential target genes, as well as to study their prognostic role. DNA methylation status was analyzed in a NSCLC patient cohort (n = 47) and compared with a control cohort including COPD patients and non-COPD subjects (n = 23) using the Illumina Infinium Human Methylation 450 BeadChip. Hypomethylation of miRNAs located on chromosome 19q13.42 was found to be specific for tumor tissue. We then identified the target mRNA–miRNA regulatory network for the components of the C19MC and MIR371-3 clusters using the miRTargetLink 2.0 Human tool. The correlations of miRNA-target mRNA expression from primary lung tumors were analyzed using the CancerMIRNome tool. From those negative correlations identified, we found that a lower expression of 5 of the target genes (FOXF2, KLF13, MICA, TCEAL1 and TGFBR2) was significantly associated with poor overall survival. Taken together, this study demonstrates that the imprinted C19MC and MIR371-3 miRNA clusters undergo polycistronic epigenetic regulation leading to deregulation of important and common target genes with potential prognostic value in lung cancer. |
format | Online Article Text |
id | pubmed-10000578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100005782023-03-11 Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer Boyero, Laura Noguera-Uclés, José Francisco Castillo-Peña, Alejandro Salinas, Ana Sánchez-Gastaldo, Amparo Alonso, Miriam Benedetti, Johana Cristina Bernabé-Caro, Reyes Paz-Ares, Luis Molina-Pinelo, Sonia Cancers (Basel) Article SIMPLE SUMMARY: Aberrations in DNA methylation profiles may alter the expression of key miRNAs in non-small cell lung cancer. In this study, we focus on the analysis of the imprinted C19MC and MIR371-3 miRNA clusters due to their oncogenic role. We identified the DNA methylation status and discovered its deregulated target genes in this disease. Additionally, we found five downstream target genes that were correlated with worse overall survival in non-small cell lung cancer. We conclude that C19MC and MIR371-3 are key players in lung cancer because their polycistronic epigenetic regulation leads to differential tumor expression, affecting downstream targets with prognostic value. ABSTRACT: Epigenetic mechanisms have emerged as an important contributor to tumor development through the modulation of gene expression. Our objective was to identify the methylation profile of the imprinted C19MC and MIR371-3 clusters in patients with non-small cell lung cancer (NSCLC) and to find their potential target genes, as well as to study their prognostic role. DNA methylation status was analyzed in a NSCLC patient cohort (n = 47) and compared with a control cohort including COPD patients and non-COPD subjects (n = 23) using the Illumina Infinium Human Methylation 450 BeadChip. Hypomethylation of miRNAs located on chromosome 19q13.42 was found to be specific for tumor tissue. We then identified the target mRNA–miRNA regulatory network for the components of the C19MC and MIR371-3 clusters using the miRTargetLink 2.0 Human tool. The correlations of miRNA-target mRNA expression from primary lung tumors were analyzed using the CancerMIRNome tool. From those negative correlations identified, we found that a lower expression of 5 of the target genes (FOXF2, KLF13, MICA, TCEAL1 and TGFBR2) was significantly associated with poor overall survival. Taken together, this study demonstrates that the imprinted C19MC and MIR371-3 miRNA clusters undergo polycistronic epigenetic regulation leading to deregulation of important and common target genes with potential prognostic value in lung cancer. MDPI 2023-02-25 /pmc/articles/PMC10000578/ /pubmed/36900258 http://dx.doi.org/10.3390/cancers15051466 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Boyero, Laura Noguera-Uclés, José Francisco Castillo-Peña, Alejandro Salinas, Ana Sánchez-Gastaldo, Amparo Alonso, Miriam Benedetti, Johana Cristina Bernabé-Caro, Reyes Paz-Ares, Luis Molina-Pinelo, Sonia Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title | Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title_full | Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title_fullStr | Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title_full_unstemmed | Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title_short | Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer |
title_sort | aberrant methylation of the imprinted c19mc and mir371-3 clusters in patients with non-small cell lung cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000578/ https://www.ncbi.nlm.nih.gov/pubmed/36900258 http://dx.doi.org/10.3390/cancers15051466 |
work_keys_str_mv | AT boyerolaura aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT noguerauclesjosefrancisco aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT castillopenaalejandro aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT salinasana aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT sanchezgastaldoamparo aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT alonsomiriam aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT benedettijohanacristina aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT bernabecaroreyes aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT pazaresluis aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer AT molinapinelosonia aberrantmethylationoftheimprintedc19mcandmir3713clustersinpatientswithnonsmallcelllungcancer |